For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251210:nRSJ0028La&default-theme=true
RNS Number : 0028L Gelion PLC 10 December 2025
10 December 2025
Gelion plc
("Gelion", the "Company" or the "Group")
Director/PDMR Shareholding - Grant of Options
Gelion plc (AIM: GELN), the global energy storage innovator, announces the
grant of options ("Options") to subscribe for new ordinary shares ("Ordinary
Shares") to Amit Gupta, Chief Financial Officer, in accordance with the terms
of the Group's Share Option Plan.
Mr Gupta was granted 284,015 Options on 5 December 2025 in recognition of
his contributions to the Group in FY25 (July 2024 to June 2025). These Options
have an exercise price of 0.1 pence and are subject to vesting and exercise
conditions of the Share Option Plan as set out below. Following this grant,
the total number of Options held by Amit Gupta is 1,251,075.
Following this issue of Options, the Group has approximately 16.69 million
Options in issue, representing 7.3% of the Company's issued share capital.
Summary of terms of these Options
These Options are consistent with allocations granted to other executives of
the Company; they will vest in three equal tranches with the final vesting
on 31 August 2028 provided on each vesting that Mr Gupta is in continuous
employment with Gelion. The Options expire, to the extent that they have not
been exercised, on 5 December 2035.
All Options are subject to both malus and clawback provisions and good and bad
leaver provisions. All unvested options will vest in certain corporate events
such as a takeover of the company or a change of control. In these
circumstances the Options would normally vest and become exercisable in full
unless the Board decides that the Option will be pro-rated to take account of
the date the corporate event took place during the normal vesting period.
Enquiries:
Gelion plc via Alma
John Wood, CEO
Amit Gupta,
CFO
Strand Hanson Limited (Nominated and Financial Adviser) +44 (0) 20 7409 3494
Christopher Raggett / Rob Patrick / Harry Marshall
Oberon Capital (Joint Broker) +44 (0) 20 3179 5300
Nick Lovering / Mike Seabrook / Adam Pollock
Allenby Capital Limited (Joint Broker) +44 (0) 20 3328 5656
Jos Pinnington / Lauren Wright (Sales and Corporate Broking)
Alex Brearley / Ashur Joseph (Corporate Finance)
Alma Strategic Communications (Financial PR) +44 (0) 20 3405 0205
Justine James / Hannah Campbell / Rose Docherty gelion@almastrategic.com (mailto:gelion@almastrategic.com)
The Notification of Dealing Form set out below is provided in accordance with
the requirements of the EU Market Abuse Regulation.
1. Details of the person discharging managerial responsibilities/person closely
associated
a) Name: Amit Gupta
2. Reason for the notification
a) Position/status: Chief Financial Officer
b) Initial notification/Amendment: Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name: Gelion plc
b) LEI: 2138008NC7YL3MCUDR84
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument: Ordinary shares of 0.1p each ("Ordinary Shares")
Identification code: GB00BNBQZD59
b) Nature of the transaction: Grant of options
c) Price(s) and volume(s): Price(s) Volume(s)
0.1p 284,015
d) Aggregated information: Single transaction as in 4 (c) above
· Aggregated volume:
· Price:
e) Date of the transaction: 5 December 2025
f) Place of the transaction: Outside of a trading venue
d)
Aggregated information:
· Aggregated volume:
· Price:
Single transaction as in 4 (c) above
e)
Date of the transaction:
5 December 2025
f)
Place of the transaction:
Outside of a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHVBLBFELLEFBD
Copyright 2019 Regulatory News Service, all rights reserved